Diabetes, Pre-Diabetes and Cardiovascular Diseases

ESC Clinical Practice Guidelines

Topics: Diabetic heart disease

21/06/2007 00:00:00

Current versions available to download

Publication date	Versions	References	Size
2007	Full Text	ESC Web Site only	1 MB
2007	Executive Summary	EHJ 2007;28:88-136	1 MB
	Pocket guidelines
	Pocket guidelines	Compendium of Abridged ESC Guidelines
	Pda	Download the PDA
	CME Questions	2 hours of External CME credits

Current translated versions available to download:

Authors

Lars Rydén FESC, Co-Chairperson, Eberhard Standl, Co-Chairperson, Małgorzata Bartnik, Greet Van den Berghe, John Betteridge, Menko-Jan de Boer, Francesco Cosentino FESC, Bengt Jonsson, Markku Laakso, Klas Malmberg FESC, Silvia G Priori FESC, Jan Ostergren, Jaakko Tuomilehto FESC, Inga S Thrainsdottir FESC

Glucose-lowering therapy with rosiglitazone

Endorsed by:

Table of contents: Full Text (ESC Clinical Practice Guidelines)

Definition, classification, and screening of diabetes and pre-diabetic glucose abnormalities
Epidemiology of diabetes, IGH, and cardiovascular risk
Identification of subjects at high risk for CVD or diabetes
Pathophysiology
Treatment to reduce cardiovascular risk
Management of CVD
Heart failure and diabetes
Arrhythmias: AF and sudden death
Peripheral and cerebrovascular disease
Intensive care
Health economics and diabetes

Previous versions

A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available here